Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Census population 200,603. Alabama Medicare wound biologics: Palmetto GBA (JJ). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Montgomery clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Montgomery storefront.
Platelet Rich Plasma (PRP) Therapy in Montgomery, AL for clinics & physicians. PRP therapy systems with 1-… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of platelet rich plasma therapy in Montgomery: (1) CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. (2) Alabama Part B wound biologics are reviewed by Palmetto GBA under JJ, shared with GA, TN. We help with the second file. We do not pretend to be a Montgomery storefront.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)Alabama shares JJ with GA, TN. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 16.7% of adults in Montgomery have diagnosed diabetes — 4.7 points above the U.S. 12% figure. Adult arthritis here is 29.7% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Montgomery.
CDC PLACES (2023, crude prevalence) estimates 16.7% of adults — 4.7 points above the U.S. 12% figure. Obesity is 46.4%; arthritis is 29.7%. That is place-level BRFSS modeling, not a clinic census and not a Montgomery trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Alabama compliance risk.
Alabama includes Diabetes Belt counties in CDC’s published geography. That supports a higher index of suspicion for DFU and chronic-wound volume. It is not a license to skip offloading, vascular assessment, or JJ documentation.
Bring specialty, monthly joint / regenerative volume, and whether you bill JJ FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 16.7% diabetes and 29.7% arthritis for Montgomery — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Montgomery, AL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Montgomery is JJ geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Montgomery — 4.7 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Alabama Part B wound biologics follow this contractor (siblings: GA, TN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Montgomery. Useful for joint-program math; still needs a diagnosis and privileging.
No Montgomery storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.